Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
BMC Health Serv Res ; 18(1): 934, 2018 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-30514376

RESUMEN

BACKGROUND: Access to quality hypertension care is often poor in sub-Saharan Africa. Some community pharmacies offer hypertension monitoring services, with and without involvement of medical doctors. To directly connect pharmacy staff and cardiologists a care model including a mobile application (mHealth) for remote patient monitoring was implemented and pilot tested in Lagos, Nigeria. Pharmacists provided blood pressure measurements and counselling. Cardiologists enrolled patients in the pilot program and remotely monitored them, for which patients paid a monthly fee. We evaluated the feasibility of this care model at five private community pharmacies. Outcome measures were retention in care, blood pressure change, quality of care, and patients' and healthcare providers' satisfaction with the care model. METHODS: Patients participated in the care model's pilot at one of the five pharmacies for approximately 6-8 months from February 2016. We conducted structured patient interviews and blood pressure measurements at pilot entry and exit, and used exports of the mHealth-application, in-depth interviews and focus group discussions with patients, pharmacists and cardiologists. RESULTS: Of 336 enrolled patients, 236 (72%) were interviewed at pilot entry and exit. According to the mHealth data 71% returned to the pharmacy after enrollment, with 3.3 months (IQR: 2.2-5.4) median duration of activity in the mHealth-application. Patients self-reported more visits than recorded in the mHealth data. Pharmacists mentioned use of paper records, understaffing, the application not being user-friendly, and patients' unwillingness to pay as reasons for underreporting. Mean systolic blood pressure decreased 9.9 mmHg (SD: 18). Blood pressure on target increased from 24 to 56% and an additional 10% had an improved blood pressure at endline, however this was not associated with duration of mHealth activity. Patients were satisfied because of accessibility, attention, adherence and information provision. CONCLUSION: Patients, pharmacists and cardiologists adopted the care model, albeit with gaps in mHealth data. Most patients were satisfied, and their mean blood pressure significantly reduced. Usage of the mHealth application, pharmacy incentives, and a modified financing model are opportunities for improvement. In addition, costs of implementation and availability of involved healthcare providers need to be investigated before such a care model can be further implemented.


Asunto(s)
Hipertensión/tratamiento farmacológico , Servicios Farmacéuticos/normas , Telemedicina/normas , Actitud del Personal de Salud , Presión Sanguínea/fisiología , Determinación de la Presión Sanguínea , Utilización de Instalaciones y Servicios , Estudios de Factibilidad , Femenino , Grupos Focales , Gastos en Salud , Personal de Salud , Humanos , Hipertensión/economía , Hipertensión/fisiopatología , Masculino , Persona de Mediana Edad , Aplicaciones Móviles/estadística & datos numéricos , Nigeria , Satisfacción del Paciente , Servicios Farmacéuticos/economía , Servicios Farmacéuticos/estadística & datos numéricos , Farmacias/economía , Farmacias/estadística & datos numéricos , Farmacéuticos , Médicos , Proyectos Piloto , Estudios Prospectivos , Autoinforme , Telemedicina/economía , Telemedicina/estadística & datos numéricos
2.
J Hypertens ; 37(2): 389-397, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30645210

RESUMEN

BACKGROUND: In sub-Saharan Africa, cardiovascular disease is becoming a leading cause of death, with high blood pressure as number one risk factor. In Nigeria, access and adherence to hypertension care are poor. A pharmacy-based hypertension care model with remote monitoring by cardiologists through mHealth was piloted in Lagos to increase accessibility to quality care for hypertensive patients. OBJECTIVES: To describe patients' and healthcare providers' perceptions and practices regarding hypertension, pharmacy-based care, and mHealth and explore how this information may improve innovative hypertension service delivery. METHODS: This study consisted of observations of patient-pharmacy staff interactions and hypertension care provided, four focus group discussions and in-depth interviews with 30 hypertensive patients, nine community pharmacists, and six cardiologists, and structured interviews with 328 patients. RESULTS: Most patients were knowledgeable about biomedical causes and treatment of hypertension, but often ignorant about the silent character of hypertension. Reasons mentioned for not adhering to treatment were side effects, financial constraints, lack of health insurance, and cultural or religious reasons. Pharmacists additionally mentioned competition with informal, cheaper healthcare providers. Patients highly favored pharmacy-based care, because of the pharmacist-patient relationship, accessibility, small-scale, and a pharmacy's registration at an association. The majority of respondents were positive towards mHealth. CONCLUSION: Facilitating factors for innovative pharmacy-based hypertension care were: patients' biomedical perceptions, pharmacies' strong position in the community, and respondents' positive attitude towards mHealth. We recommend health education and strengthening pharmacists' role to address barriers, such as misperceptions that hypertension always is symptomatic, treatment nonadherence, and unfamiliarity with mHealth. Future collaboration with insurance providers or other financing mechanisms may help diminish patients' financial barriers to appropriate hypertension treatment.


Asunto(s)
Actitud del Personal de Salud , Servicios Comunitarios de Farmacia , Atención a la Salud/métodos , Hipertensión/tratamiento farmacológico , Satisfacción del Paciente , Telemedicina , Adulto , Anciano , Anciano de 80 o más Años , Cardiología , Femenino , Grupos Focales , Accesibilidad a los Servicios de Salud , Humanos , Entrevistas como Asunto , Masculino , Cumplimiento de la Medicación , Persona de Mediana Edad , Nigeria , Farmacia
3.
BMJ Open ; 8(9): e019642, 2018 09 08.
Artículo en Inglés | MEDLINE | ID: mdl-30196265

RESUMEN

OBJECTIVE: To determine which service models and organisational structures are effective and cost-effective for delivering tuberculosis (TB) services to hard-to-reach populations. DESIGN: Embase and MEDLINE (1990-2017) were searched in order to update and extend the 2011 systematic review commissioned by National Institute for Health and Care Excellence (NICE), discussing interventions targeting service models and organisational structures for the identification and management of TB in hard-to-reach populations. The NICE and Cochrane Collaboration standards were followed. SETTING: European Union, European Economic Area, European Union candidate countries and Organisation for Economic Co-operation and Development countries. PARTICIPANTS: Hard-to-reach populations, including migrants, homeless people, drug users, prisoners, sex workers, people living with HIV and children within vulnerable and hard-to-reach populations. PRIMARY AND SECONDARY OUTCOME MEASURES: Effectiveness and cost-effectiveness of the interventions. RESULTS: From the 19 720 citations found, five new studies were identified, in addition to the six discussed in the NICE review. Community health workers from the same migrant community, street teams and peers improved TB screening uptake by providing health education, promoting TB screening and organising contact tracing. Mobile TB clinics, specialised TB clinics and improved cooperation between healthcare services can be effective at identifying and treating active TB cases and are likely to be cost-effective. No difference in treatment outcome was detected when directly observed therapy was delivered at a health clinic or at a convenient location in the community. CONCLUSIONS: Although evidence is limited due to the lack of high-quality studies, interventions using peers and community health workers, mobile TB services, specialised TB clinics and improved cooperation between health services can be effective to control TB in hard-to-reach populations. Future studies should evaluate the (cost-)effectiveness of interventions on TB identification and management in hard-to-reach populations and countries should be urged to publish the outcomes of their TB control systems. PROSPERO REGISTRATION NUMBER: CRD42015017865.


Asunto(s)
Atención a la Salud/organización & administración , Educación en Salud/organización & administración , Modelos Organizacionales , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/epidemiología , Agentes Comunitarios de Salud/organización & administración , Consumidores de Drogas , Europa (Continente) , Infecciones por VIH/epidemiología , Personas con Mala Vivienda , Humanos , Incidencia , Israel , Unidades Móviles de Salud/organización & administración , Grupo Paritario , Prisioneros , Trabajadores Sexuales , Migrantes , Tuberculosis Pulmonar/tratamiento farmacológico , Estados Unidos
4.
Int Health ; 10(6): 490-494, 2018 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-30165402

RESUMEN

Introduction: In Sudan, echinococcosis (EC) is a chronic neglected zoonotic parasitic disease caused by Echinococcus granulosus. Studies have shown high prevalence rates in dogs (50-70%), camels (35%) and sheep, goats and cattle (10-11%). In total, 0.3-1.0% of humans in Central and South Sudan are infected with the G6 camel strain. This strain is almost exclusively the cause of human infections. The objective of this study was to explore knowledge, attitudes and practices (KAP) regarding the disease among people living around Tambool city, Central Sudan. Methods: A cross-sectional survey was conducted in three villages around the city of Tambool in Central Sudan. Three-hundred-and-twelve households were selected from the administrative unit of the area for participation in the study, of which 300 agreed to partake. A standardized questionnaire was designed to collect data on EC in animals, humans and the environment. The questionnaire domains were socio-demographic characteristics, KAP regarding echinococcosis. Results: The population surveyed showed that 68.7% (206/300) had never heard of the disease, while 31.3% (94/300) had heard about it. The level of knowledge among the 31.3% of those that had heard about the disease was excellent (69/94; 73.4%); so were their attitudes (76/94; 80.9%). However, the majority of the participants (64/94; 68%) showed poor practice regarding this disease, enhancing the odds for further propagation of parasite circulation in the animal and human populations at risk. Knowledge was found to be significantly associated with marital status. Practice was found to be significantly associated with occupation. Conclusions: There is a need for the implementation of a multidisciplinary program using the One Health approach to effectively control and prevent EC.


Asunto(s)
Enfermedades de los Animales/epidemiología , Equinococosis/epidemiología , Conocimientos, Actitudes y Práctica en Salud , Adolescente , Adulto , Animales , Niño , Preescolar , Estudios Transversales , Echinococcus granulosus , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Prevalencia , Factores Socioeconómicos , Sudán del Sur/epidemiología , Adulto Joven
5.
Lancet Infect Dis ; 17(5): e128-e143, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28291721

RESUMEN

Tuberculosis disproportionately affects hard-to-reach populations, such as homeless people, migrants, refugees, prisoners, or drug users. These people often face challenges in accessing quality health care. We did a systematic review of the qualitative literature to identify barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by people from hard-to-reach populations in all European Union (EU), European Economic Area, EU candidate, and Organisation for Economic Co-operation and Development countries. The 12 studies included in this review mainly focused on migrants. Views on perceived susceptibility to and severity of tuberculosis varied widely and included many misconceptions. Stigma and challenges regarding access to health care were identified as barriers to tuberculosis diagnosis and treatment uptake, whereas support from nurses, family, and friends was a facilitator for treatment adherence. Further studies are required to identify barriers and facilitators to the improved identification and management of tuberculosis in hard-to-reach populations to inform recommendations for more effective tuberculosis control programmes.


Asunto(s)
Accesibilidad a los Servicios de Salud , Migrantes/psicología , Tuberculosis/diagnóstico , Tuberculosis/tratamiento farmacológico , Unión Europea , Familia/psicología , Personas con Mala Vivienda/psicología , Humanos , América del Norte , Investigación Cualitativa , Estigma Social
6.
Lancet Infect Dis ; 17(5): e144-e158, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28291722

RESUMEN

Tuberculosis is over-represented in hard-to-reach (underserved) populations in high-income countries of low tuberculosis incidence. The mainstay of tuberculosis care is early detection of active tuberculosis (case finding), contact tracing, and treatment completion. We did a systematic review with a scoping component of relevant studies published between 1990 and 2015 to update and extend previous National Institute for Health and Care Excellence (NICE) reviews on the effectiveness of interventions for identifying and managing tuberculosis in hard-to-reach populations. The analyses showed that tuberculosis screening by (mobile) chest radiography improved screening coverage and tuberculosis identification, reduced diagnostic delay, and was cost-effective among several hard-to-reach populations. Sputum culture for pre-migration screening and active referral to a tuberculosis clinic improved identification. Furthermore, monetary incentives improved tuberculosis identification and management among drug users and homeless people. Enhanced case management, good cooperation between services, and directly observed therapy improved treatment outcome and compliance. Strong conclusions cannot be drawn because of the heterogeneity of evidence with regard to study population, methodology, and quality.


Asunto(s)
Tamizaje Masivo/métodos , Tuberculosis/diagnóstico , Tuberculosis/tratamiento farmacológico , Análisis Costo-Beneficio , Consumidores de Drogas/psicología , Salud Global , Personas con Mala Vivienda/psicología , Humanos , Tamizaje Masivo/economía , Motivación , Migrantes/psicología , Tuberculosis/diagnóstico por imagen
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA